Skip to content
powderbulkvideos.com
Menu

Industry

Pharmaceuticals

Answer in brief

Pharmaceutical solid-dose production transfers APIs and excipients through closed, GMP-compliant systems that protect the product, the operator and the environment. Selection is driven by containment performance for potent compounds, validated cleaning, blend uniformity and full batch documentation under FDA cGMP and EU GMP.

Reviewed August 13, 2026 · Updated August 13, 2026

Contained IBC blending and powder transfer station in a pharmaceutical cleanroom

Process challenges

Blend uniformity and segregation control decide product quality — transfer steps after blending must not de-mix the product. Small batch sizes and frequent changeovers demand fast, validated cleaning or dedicated disposable paths. Potent-compound handling requires engineered containment verified by surrogate testing rather than PPE alone. Scale-up from development to production must preserve flow and blend behavior.

Material challenges

APIs are often cohesive, micronized, electrostatic and available only in small quantities. Excipients range from free-flowing lactose grades to poorly flowing celluloses. Moisture-sensitive formulations require humidity-controlled handling; low-dose formulations amplify any segregation into content-uniformity failures.

Hygiene requirements

GMP hygienic design uses crevice-free, polished product-contact surfaces, documented materials, and cleanability that supports validated cleaning with defined acceptance limits. Closed transfer minimizes open handling; sampling is contained. Cross-contamination control between products is a regulatory expectation, with dedicated equipment where risk assessment requires it.

Safety requirements

Operator protection for potent APIs relies on engineered containment — isolators, split valves, contained transfer — assessed against containment performance targets using the SMEPAC/ISPE test methodology. Many organic excipients and APIs are combustible dusts, so explosion prevention (inerting, venting, isolation) applies to mills, dryers, blenders and dust collection alongside GMP requirements.

Regulatory context

US operations follow FDA cGMP (21 CFR 210/211); the EU applies EudraLex Volume 4 GMP with its annexes. Containment practice is benchmarked using the ISPE SMEPAC guideline for particulate containment performance. Cleaning validation, data integrity and batch documentation expectations apply across both regimes.

Partner with powderbulkvideos.com

Put a relevant technical solution in this decision path.

Connect your company and video evidence with clearly labelled visibility where engineers evaluate this material, application, industry or product.

Work with us View partnership options

Related content

Continue exploring

Move from this page to the companies, videos and technical topics that add useful context.

Companies

Videos

On this page